Correlation Between Inozyme Pharma and Cara Therapeutic
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Cara Therapeutic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Cara Therapeutic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Cara Therapeutic, you can compare the effects of market volatilities on Inozyme Pharma and Cara Therapeutic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Cara Therapeutic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Cara Therapeutic.
Diversification Opportunities for Inozyme Pharma and Cara Therapeutic
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Inozyme and Cara is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Cara Therapeutic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cara Therapeutic and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Cara Therapeutic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cara Therapeutic has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Cara Therapeutic go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Cara Therapeutic
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Cara Therapeutic. In addition to that, Inozyme Pharma is 1.53 times more volatile than Cara Therapeutic. It trades about -0.3 of its total potential returns per unit of risk. Cara Therapeutic is currently generating about 0.09 per unit of volatility. If you would invest 475.00 in Cara Therapeutic on November 9, 2024 and sell it today you would earn a total of 37.00 from holding Cara Therapeutic or generate 7.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Cara Therapeutic
Performance |
| Timeline |
| Inozyme Pharma |
| Cara Therapeutic |
Inozyme Pharma and Cara Therapeutic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Cara Therapeutic
The main advantage of trading using opposite Inozyme Pharma and Cara Therapeutic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Cara Therapeutic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cara Therapeutic will offset losses from the drop in Cara Therapeutic's long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Cara Therapeutic vs. 22nd Century Group | Cara Therapeutic vs. Corbus Pharmaceuticals Holding | Cara Therapeutic vs. Cannabis Sativa | Cara Therapeutic vs. General Cannabis Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |